| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Von Koch Thomas is a 10% Owner at DiaMedica Therapeutics Inc.. Recent SEC Form 4 filings include 5 buys and 1 sell.
Estimated insider holdings value: $54.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 23, 2025 | DMAC Diamedica Therapeutics Inc. | 10% Owner | Buy | 2,857,142 | $3.50 | $9,999,997.00 | +51.7% | +28.5% | - | |
| Jun 28, 2024 | DMAC Diamedica Therapeutics Inc. | 10% Owner | Buy | 1,200,000 | $2.50 | $3,000,000.00 | +27.7% | +45.8% | +30.2% | |
| Jun 23, 2023 | DMAC Diamedica Therapeutics Inc. | 10% Owner | Buy | 1,470,588 | $3.40 | $4,999,999.20 | +51.5% | -29.4% | -49.2% | |
| Dec 2, 2022 | DMAC Diamedica Therapeutics Inc. | 10% Owner | Sell | 2,855,847 | $1.24 | $3,526,971.05 | -100% | +22.3% | +75.0% | |
| Dec 2, 2022 | DMAC Diamedica Therapeutics Inc. | 10% Owner | Buy | 2,855,847 | $1.24 | $3,526,971.05 | New | +22.3% | +75.0% | |
| Jul 8, 2022 | DMAC Diamedica Therapeutics Inc. | 10% Owner | Buy | 207,974 | $1.33 | $275,898.31 | +7.9% | -1.5% | +191.1% |